RecallDepth
Class II Terminated

Haloperidol Decanoate Injection 100 mg/mL, packaged in a) 1 mL single-dose vials (NDC 0703-7131-01), b) 5 mL multi-dose vials (NDC 0703-7133-01), Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454.

Company
Teva Pharmaceuticals Usa
Recall Initiated
July 29, 2021
Posted
August 25, 2021
Recall Number
D-0732-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
16,226 vials
Firm Location
Parsippany, NJ, United States

Reason for Recall

Lack of Assurance of Sterility

Distribution

Product was distributed Nationwide, including Puerto Rico.

Lot / Code Info

Lot #: a) 31327056B, exp. date 03/2022; 31328547B, exp. date 01/2023; b) 31327066B, exp. date 03/2022

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls